Steven A. Kriegsman, Director at RXI PHARMACEUTICALS CORP (RXII), sold 9,551 shares at $4.42 ($41K) on 2009-05-06, disclosed to the SEC on 2009-05-07.
Scheduled sale ($41k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $4.18 | 5,500 | $23K | 56.2% |
| 2 | $4.42 | 4,051 | $18K | 43.8% |
| Total | $4.28 avg | 9,551 | $41K | 100% |
| Filing → |
| CYTR | BUY | 2012-02-24 | $51K | — | Filing → |
| RXII | SELL | 2009-08-20 | $28K | — | Filing → |
| RXII | SELL | 2009-07-06 | $13K | — | Filing → |